NYMOX PHARMACEUTICAL CORP (NYMX) Stock Analyst Earnings Estimates
NASDAQ:NYMX - Nasdaq - BSP733981026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 300K 36.36% | 120K -60.00% | 10K -91.67% | N/A -100.00% | N/A | |
| EBITDA YoY % growth | -10.64M 19.64% | -13.32M -25.19% | -11.71M 12.09% | N/A -6.68% | N/A 46.85% | |
| EBIT YoY % growth | -10.64M 19.64% | -13.33M -25.28% | -11.72M 12.08% | N/A -6.69% | N/A 46.80% | |
| Operating Margin | -3,546.67% | -11,108.33% | -117,200.00% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | 10K -66.67% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |